Rahul Singhvi, Resilience CEO
February 17, 2022 12:39 PM EST
Manufacturing

Re­silience moves Cana­di­an site in­to plas­ma ther­a­pies, as it signs deal with Take­da

Josh Sullivan

Re­silience has land­ed an­oth­er part­ner in its quest to be­come the Ama­zon Web Ser­vices of drug man­u­fac­tur­ing, and it will use its Cana­di­an foot­print to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Mi­crosoft-backed Enve­da rais­es $130M for drugs in I&I, obe­si­ty and oth­er ar­eas

As­traZeneca culls Phase 2 opi­oid use dis­or­der drug

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times